Determination of 3-Cyanobenzyl Bromide and 4-Cyanobenzyl Bromide in 2-Cyanobenzyl Bromide by GC-MS/MS
摘 要
建立了气相色谱-串联质谱法测定苯甲酸阿格列汀关键起始物料2-氰基溴苄中基因毒性杂质3-氰基溴苄和4-氰基溴苄含量的分析方法。采用50%苯基-50%二甲基聚硅氧烷为固定液的VF-17MS毛细管柱(30 m×0.25 mm,0.25 μm)进行程序升温;进样口温度260℃;以多反应监测(MRM)模式检测。2种待测物均具有较好的线性关系,相关系数均大于0.998 0;检出限(3S/N)均为2.0 μg·L-1;3-氰基溴苄的回收率为92.1%~97.0%;4-氰基溴苄的回收率为102%~109%;供试品溶液、杂质对照品溶液和系统适用性溶液在室温(25℃)下放置18 h内稳定。三批生产规模样品中均未检出3-氰基溴苄和4-氰基溴苄。建立的分析方法灵敏度高、分离度好、结果准确,可有效分离并测定2-氰基溴苄中的3-氰基溴苄和4-氰基溴苄含量,为苯甲酸阿格列汀的安全性提供了保障。
Abstract
An analytical method of GC-MS/MS was established for the simultaneous determination of 3-cyanobenzyl bromide and 4-cyanobenzyl bromide in 2-cyanobenzyl bromide used in aglitine benzoate. The method was performed on a VF-17MS capillary column (50% benzene-50% dimethylsiloxane copolymer, 30 m×0.25 mm, 0.25 μm). The column temperature was risen by program. The injector temperature was controlled at 260℃. The analytes were detected with MS/MS in multiple reaction monitoring (MRM) mode. The method was found to show good linearity with regression coefficients all more than 0.998 0. The limits of detection (3S/N) all were 2.0 μg·L-1. The recoveries of 3-cyanobenzyl bromide were 92.1%-97.0%. And the recoveries of 4-cyanobenzyl bromide were 102%-109%. The test solution, reference solution and system suitability solution were stable for at least 18 h at 25℃. No 3-cyanobenzyl bromide and 4-cyanobenzyl bromide were detected in three batches of production scale samples. With high sensitivity, good resolution and accuracy, the method could be reliably and effectively used in the determination of the above two kinds of trace impurities in 2-cyanobenzyl bromide. This method provides a guarantee for the safety of alogliptin benzoate.
中图分类号 O657.63 DOI 10.11973/lhjy-hx202004011
所属栏目 工作简报
基金项目
收稿日期 2019/8/14
修改稿日期
网络出版日期
作者单位点击查看
备注庄航,副主任药师,主要从事药品检验及药品质量标准研究工作,603994838@qq.com
引用该论文: ZHUANG Hang. Determination of 3-Cyanobenzyl Bromide and 4-Cyanobenzyl Bromide in 2-Cyanobenzyl Bromide by GC-MS/MS[J]. Physical Testing and Chemical Analysis part B:Chemical Analysis, 2020, 56(4): 438~442
庄航. 气相色谱-串联质谱法测定2-氰基溴苄中3-氰基溴苄和4-氰基溴苄的含量[J]. 理化检验-化学分册, 2020, 56(4): 438~442
共有人对该论文发表了看法,其中:
人认为该论文很差
人认为该论文较差
人认为该论文一般
人认为该论文较好
人认为该论文很好
参考文献
【1】FENG J, ZHANG Z Y, WALLACE M, et al. Discovery of alogliptin:A potent, selective, a bioavailable, and efficacious inhibitor of dipeptidyl peptidase Ⅳ[J]. Journal of Medicinal Chemistry, 2007,50(10):2297-2300.
【2】PRATLEY R E. Alogliptin:A new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes[J]. Expert Opinion on Pharmacotherapy, 2009,10(3):503-512.
【3】SYRRX I, FENG JUN, GWALTNEY SL, et al. Dipeptidyl peptidase inhibitors:WO, 2005095381A1[P]. 2005-10-13.
【4】Takeda Pharmaceutical. Dipeptidyl peptidase inhibitors:WO, 2007035629A2[P]. 2006-09-15.
【5】ANDUKURI R, DRINCIC A, RENDELL M. Alogliptin:A new addition to the class of DPP-4 inhibitors[J]. Diabetes, Metabolic Syndrome and Obesity:Targetsand Therapy, 2009,2:117-126.
【6】韩在褀,刘颖,马晶杰,等.苯甲酸阿格列汀合成工艺的改进[J].化学试剂, 2018,40(12):1216-1219.
【7】TAILLADES J, BOITEAU L, BEUZELIN I, et al. A pH-dependent cyanate reactivity model:application to preparative N-carbamoylation of amino acids[J]. Journal of the Chemical Society, Perkin Transactions 2, 2001,2(7):1247-1254.
【8】MIRJAFARI A, MOHAMMADPOOR-BALTORK I, MOGHADAM M, et al. Microwave-promoted, one-pot conversion of alkoxymethylatedprotected alcohols into their corresponding nitriles, bromides, and iodides using[bmim] [InCl4] as a green catalyst[J]. Tetrahedron Letters, 2010,51(25):3274-3276.
【9】GOLD L, SLONE T, SWIRSKY, et al. The carcinogenic potency database (CPDB)[M]. California:University of Berkeley, 2000.
【10】ROBINSON D I. Control of genotoxic impurities in active pharmaceutical ingredients:Areview and perspective[J]. Organic Process Research and Development, 2010,14(4):946-959.
【11】International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk[EB/OL].[2017-05-31] http://www.ich.org/products/guidelines/multidisciplinary/article/multidisciplinary-guidelines.html.
【12】马磊,马玉楠,陈震,等.遗传毒性杂质的警示结构[J].中国新药杂志, 2014,23(18):2106-2111.
【13】秦立,胡昌勤.气相色谱保留时间预测在药品残留溶剂测定中的应用[J].药物分析杂志, 2006,26(10):1469-1476.
【14】张兴龙.气相色谱不同操作模式下的程序升温保留时间的预测[D].天津:天津大学, 2016.
【2】PRATLEY R E. Alogliptin:A new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes[J]. Expert Opinion on Pharmacotherapy, 2009,10(3):503-512.
【3】SYRRX I, FENG JUN, GWALTNEY SL, et al. Dipeptidyl peptidase inhibitors:WO, 2005095381A1[P]. 2005-10-13.
【4】Takeda Pharmaceutical. Dipeptidyl peptidase inhibitors:WO, 2007035629A2[P]. 2006-09-15.
【5】ANDUKURI R, DRINCIC A, RENDELL M. Alogliptin:A new addition to the class of DPP-4 inhibitors[J]. Diabetes, Metabolic Syndrome and Obesity:Targetsand Therapy, 2009,2:117-126.
【6】韩在褀,刘颖,马晶杰,等.苯甲酸阿格列汀合成工艺的改进[J].化学试剂, 2018,40(12):1216-1219.
【7】TAILLADES J, BOITEAU L, BEUZELIN I, et al. A pH-dependent cyanate reactivity model:application to preparative N-carbamoylation of amino acids[J]. Journal of the Chemical Society, Perkin Transactions 2, 2001,2(7):1247-1254.
【8】MIRJAFARI A, MOHAMMADPOOR-BALTORK I, MOGHADAM M, et al. Microwave-promoted, one-pot conversion of alkoxymethylatedprotected alcohols into their corresponding nitriles, bromides, and iodides using[bmim] [InCl4] as a green catalyst[J]. Tetrahedron Letters, 2010,51(25):3274-3276.
【9】GOLD L, SLONE T, SWIRSKY, et al. The carcinogenic potency database (CPDB)[M]. California:University of Berkeley, 2000.
【10】ROBINSON D I. Control of genotoxic impurities in active pharmaceutical ingredients:Areview and perspective[J]. Organic Process Research and Development, 2010,14(4):946-959.
【11】International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk[EB/OL].[2017-05-31] http://www.ich.org/products/guidelines/multidisciplinary/article/multidisciplinary-guidelines.html.
【12】马磊,马玉楠,陈震,等.遗传毒性杂质的警示结构[J].中国新药杂志, 2014,23(18):2106-2111.
【13】秦立,胡昌勤.气相色谱保留时间预测在药品残留溶剂测定中的应用[J].药物分析杂志, 2006,26(10):1469-1476.
【14】张兴龙.气相色谱不同操作模式下的程序升温保留时间的预测[D].天津:天津大学, 2016.
相关信息